You searched for "neuropathy"
Optos announces new ultra-widefield colour image modality, providing additional retinal visualisation to eyecare professionals
Optos, Plc, the leading retinal imaging company, announces it is expanding the optomap® ultra-widefield (UWF™) retinal imaging modalities available with the California FA device to further assist eyecare professionals in disease management and treatment planning.Fife councillors experience street obstacles wearing sight loss simulation-spectacles
A cross-party group of Dunfermline Councillors tried to navigate around obstacles and clutter on the streets of Dunfermline on the morning of Friday, November 24th wearing spectacles that mimic different sight loss conditions.
Long-term outcomes of intravitreal ranibizumab for neovascular AMD
This is a single centre prospective study for the long-term, whole population ‘real-world’ clinical outcomes of ranibizumab therapy in treatment-naïve patients for neovascular age-related macular degeneration (AMD). This study recorded: demographics, Early Treatment Diabetic Retinopathy Study visual acuity (ETDRS VA)...
OCT angiography and retinal vein occlusions
In this retrospective, observational case series, the authors set out to evaluate the morphology of the superficial and deep capillary plexa of eyes that suffered a retinal vein occlusion (RVO) on OCT angiography (OCTA) and compare the findings with fluorescein...
How does cataract surgery affect eyes with wet AMD?
In this retrospective cohort study the authors’ primary objective was to assess whether cataract surgery in eyes with wet age-related macular degeneration (AMD), triggered its progression. The surgical group comprised of 40 eyes versus 42 eyes in the non-surgical control...
OCTA in diabetic macular oedema treated with intravitreal aflibercept (DOCTA Study)
Central vision loss due to diabetic macular oedema (DME) can be attributed not only to presence of the macular oedema itself but also, in some cases, to alterations of the foveal avascular zone (FAZ). The DOCTA trial was a longitudinal,...
Retinal morphology after PASCAL PRP treatment
The authors of this prospective cohort study set out to report the changes on Spectral Domain-OCT of PASCAL panretinal laser photocoagulation (PRP) treatment for proliferative diabetic retinopathy (PDR) or severe nonproliferative DR (NPDR) and the retinal morphology, from one hour...NEOS (North of England Ophthalmological Society) Summer Meeting (Wetherby 19)
By Ritu Chaturvedi, ST5, Northwest Deanery. The North of England Ophthalmological Society (NEOS) summer meeting 2019 was convened by Andy Chung, Pinderfields Hospital, and the main theme was ‘Beyond excellence in ophthalmology’. An engaging programme attracted a good attendance and...Kabgayi International Ophthalmology Conference 2024
by Michael Mikhail, FRCOphth, Consultant Ophthalmologist; Vitreoretinal Surgeon, Kabgayi Eye Unit, Rwanda. My journey to Rwanda in April 2022 aimed to expand vitreoretinal services, but it also highlighted the need for robust scientific discourse, akin to the UK's ophthalmology culture,...Michael Burdon to begin term of office as a BCPB Trustee
Michael Burdon begins his term of office as a BCPB Trustee in July 2020, and in October 2020 will become Chairman of the Council when Paul Hunter retires after six years.British Council for Prevention of Blindness has a new Chairman
BCPB’s new Chairman Mr Michael Burdon FRCOphth FRCP is a consultant ophthalmologist at Queen Elizabeth Hospital Birmingham with a specialist interest in neuro-ophthalmology.
